The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease
International Journal of COPD Jan 26, 2018
Zhang M, et al. - The link between serum cyclophilin A (CyPA) and chronic obstructive pulmonary disease (COPD) was explored herein. Findings suggested that serum CyPA can be used as a potential inflammatory biomarker for COPD. Moreover, the severity of inflammation in COPD may be indicated by an evaluation of serum CyPA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries